PetVivo launches three CE courses on osteoarthritis treatments

PetVivo Animal Health, a subsidiary of PetVivo Holdings Inc. (OTCQX: PETV), announced the launch of three continuing education courses for veterinary professionals. The courses focus on osteoarthritis management and regenerative therapies for small animal and equine patients.

Each program offers one credit hour and has received approval from the Registry of Approved Continuing Education. The courses combine research with case-driven instruction developed by practicing veterinarians with expertise in surgery and rehabilitation.

The three courses include an introductory program on osteoarthritis care in small animal practice, an advanced course on joint injection techniques for small animals, and a program examining regenerative therapies in equine practice. The equine course covers treatment modalities including platelet-rich plasma, mesenchymal stem cells, and biomaterial-based devices.

"These programs were designed to deliver both a strong scientific foundation and hands-on clinical perspective," said April Boyce, Vice President of Sales and Marketing at PetVivo Animal Health. "By combining pathophysiology, therapeutic mechanisms, and case applications, veterinary professionals gain tools to evaluate candidates for regenerative options and implement protocols that move beyond symptomatic relief toward supporting joint health at the source."

The courses are available at no cost to veterinarians, veterinary technicians, and allied professionals. PetVivo Animal Health develops veterinary medical devices and regenerative therapies for osteoarthritis and joint-related conditions. The company's products include Spryng with OsteoCushion Technology and PrecisePRP, a platelet-rich plasma product.

You May Also Be Interested In

• Boeing names Ryan Shedd as new SVP and controller
• enVVeno Medical (NVNO) files $100M mixed shelf
• Hinge Health signs $86M office lease in San Francisco